Advertisement
Screener

PALATIN TECHNOLOGIES, INC. (PTN) Unrealized Gain (Loss) on Investments

2.0 / 5 stars · 28/71 Roast Me

PALATIN TECHNOLOGIES, INC. Unrealized Gain (Loss) on Investments

PALATIN TECHNOLOGIES, INC. (PTN) reported Unrealized Gain (Loss) on Investments of $0 for the 12-month period ending 2020-06-30, per its 10-K filed 2020-09-25.

Discontinued › Cash Flow › Operating Activities

us-gaap:UnrealizedGainLossOnInvestments · last filed 2020-09-25

  • PALATIN TECHNOLOGIES, INC. unrealized gain (loss) on investments for the quarter ending 2019-06-30 was $0.00.
  • PALATIN TECHNOLOGIES, INC. unrealized gain (loss) on investments for the quarter ending 2019-03-31 was $0.00.
  • PALATIN TECHNOLOGIES, INC. unrealized gain (loss) on investments for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
  • PALATIN TECHNOLOGIES, INC. unrealized gain (loss) on investments for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
  • PALATIN TECHNOLOGIES, INC. unrealized gain (loss) on investments for fiscal 2020 was $0.00.
  • PALATIN TECHNOLOGIES, INC. unrealized gain (loss) on investments for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
  • PALATIN TECHNOLOGIES, INC. unrealized gain (loss) on investments for fiscal 2018 was $590.00, a 0.00% change from fiscal 2017.
  • PALATIN TECHNOLOGIES, INC. unrealized gain (loss) on investments for fiscal 2017 was $590.00.
Period endUnrealized Gain (Loss) on Investments 3 monthUnrealized Gain (Loss) on Investments 3 month as first filedUnrealized Gain (Loss) on Investments 6 monthUnrealized Gain (Loss) on Investments 6 month as first filedUnrealized Gain (Loss) on Investments 9 monthUnrealized Gain (Loss) on Investments 9 month as first filedUnrealized Gain (Loss) on Investments 12 monthUnrealized Gain (Loss) on Investments 12 month as first filed
2020-06-30$0.00
10-K · filed 2020-09-25
2019-06-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25
$0.00
derived: sum of 2 quarters · filed 2020-09-25
$0.00
derived: sum of 3 quarters · filed 2020-09-25
$0.00
10-K · filed 2020-09-25
2019-03-31$0.00
10-Q · filed 2019-05-09
$0.00
derived: sum of 2 quarters · filed 2019-05-09
$0.00
10-Q · filed 2019-05-09
$0.00
derived: sum of 4 quarters · filed 2019-09-12
2018-12-31$0.00
10-Q · filed 2019-02-11
$0.00
10-Q · filed 2019-02-11
$0.00
derived: sum of 3 quarters · filed 2019-09-12
$0.00
derived: sum of 4 quarters · filed 2019-09-12
2018-09-30$0.00
10-Q · filed 2018-11-09
$0.00
derived: sum of 2 quarters · filed 2019-09-12
$0.00
derived: sum of 3 quarters · filed 2019-09-12
$153.00
derived: sum of 4 quarters · filed 2019-09-12
2018-06-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-12
$0.00
derived: sum of 2 quarters · filed 2019-09-12
$153.00
derived: sum of 3 quarters · filed 2019-09-12
$590.00
10-K · filed 2019-09-12
2018-03-31$0.00
10-Q · filed 2019-05-09
$153.00
derived: sum of 2 quarters · filed 2019-05-09
$590.00
10-Q · filed 2019-05-09
$655.00
derived: sum of 4 quarters · filed 2020-09-25
2017-12-31$153.00
10-Q · filed 2019-02-11
$590.00
10-Q · filed 2019-02-11
$655.00
derived: sum of 3 quarters · filed 2020-09-25
$1.24K
derived: sum of 4 quarters · filed 2020-09-25
2017-09-30$437.00
10-Q · filed 2018-11-09
$502.00
derived: sum of 2 quarters · filed 2020-09-25
$1.09K
derived: sum of 3 quarters · filed 2020-09-25
$1.60K
derived: sum of 4 quarters · filed 2020-09-25
2017-06-30$65.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25
$652.00
derived: sum of 2 quarters · filed 2020-09-25
$1.17K
derived: sum of 3 quarters · filed 2020-09-25
$590.00
10-K · filed 2020-09-25
$1.35K
10-K · filed 2017-09-25
2017-03-31$587.00
10-Q · filed 2018-05-14
$1.10K
derived: sum of 2 quarters · filed 2018-05-14
$525.00
10-Q · filed 2018-05-14
$3.85K
derived: sum of 4 quarters · filed 2018-09-13
2016-12-31$515.00
10-Q · filed 2018-02-12
-$62.00
10-Q · filed 2018-02-12
$3.26K
derived: sum of 3 quarters · filed 2018-09-13
$10.08K
derived: sum of 4 quarters · filed 2018-09-13
2016-09-30-$577.00
10-Q · filed 2017-11-13
$2.75K
derived: sum of 2 quarters · filed 2018-09-13
$9.57K
derived: sum of 3 quarters · filed 2018-09-13
$179.00
derived: sum of 4 quarters · filed 2018-09-13
2016-06-30$3.33K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-13
$10.14K
derived: sum of 2 quarters · filed 2018-09-13
$756.00
derived: sum of 3 quarters · filed 2018-09-13
-$1.94K
10-K · filed 2018-09-13
2016-03-31$6.82K
10-Q · filed 2017-05-15
-$2.57K
derived: sum of 2 quarters · filed 2017-05-15
-$5.27K
10-Q · filed 2017-05-15
-$2.57K
10-Q · filed 2016-05-16
-$2.57K
derived: sum of 4 quarters · filed 2017-09-25
2015-12-31-$9.39K
10-Q · filed 2017-02-10
$9.39K
10-Q · filed 2016-02-12
-$9.39K
10-Q · filed 2017-02-10
$9.39K
10-Q · filed 2016-02-12
-$9.39K
derived: sum of 3 quarters · filed 2017-09-25
-$9.39K
derived: sum of 4 quarters · filed 2017-09-25
2015-09-30$0.00
10-Q · filed 2016-11-14
$0.00
derived: sum of 2 quarters · filed 2017-09-25
$0.00
derived: sum of 3 quarters · filed 2017-09-25
$0.00
derived: sum of 4 quarters · filed 2017-09-25
2015-06-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25
$0.00
derived: sum of 2 quarters · filed 2017-09-25
$0.00
derived: sum of 3 quarters · filed 2017-09-25
$0.00
10-K · filed 2017-09-25
2015-03-31$0.00
10-Q · filed 2016-05-16
$0.00
derived: sum of 2 quarters · filed 2016-05-16
$0.00
10-Q · filed 2016-05-16
2014-12-31$0.00
10-Q · filed 2016-02-12
$0.00
10-Q · filed 2016-02-12
2014-06-30$0.00
10-K · filed 2016-09-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lipocine Inc. (LPCN)United States$0.017B-1.79
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Rocket One Inc. (RKTO)United States$0.019B
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B